Skip to main content
SpringerLink
Log in

Magnetic Resonance of Cardiomyopathies and Myocarditis

  • Chapter
Cardiovascular Magnetic Resonance Imaging

Part of the book series: Contemporary Cardiology ((CONCARD))

Abstract

Cardiomyopathies (CMPs) include dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), and arrhythmogenic right ventricular cardiomyopathy (ARVC) (1). Other forms of acute and chronic nonischemic myocardial diseases have been detected, with stress-induced CMP and noncompaction CMP the most vividly discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996;93:841–842.

    Article  PubMed  CAS  Google Scholar 

  2. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077–1084.

    Article  PubMed  CAS  Google Scholar 

  3. Michaely HJ, Nael K, Schoenberg SO, et al. Analysis of cardiac function—comparison between 1.5 T and 3.0 T cardiac cine magnetic resonance imaging: preliminary experience. Invest Radiol 2006;41:133–140.

    Article  PubMed  Google Scholar 

  4. Alfakih K, Thiele H, Plein S, Bainbridge GJ, Ridgway JP, Sivananthan MU. Comparison of right ventricular volume measurement between segmented k-space gradient-echo and steady-state free precession magnetic resonance imaging. J Magn Reson Imaging 2002;16:253–258.

    Article  PubMed  Google Scholar 

  5. Bellenger NG, Burgess MI, Ray SG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 2000;21:1387–1396.

    Article  PubMed  CAS  Google Scholar 

  6. Pennell DJ. T 2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci 2005;1054:373–378.

    Article  PubMed  CAS  Google Scholar 

  7. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T 2-star (T 2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171–2179.

    Article  PubMed  CAS  Google Scholar 

  8. Matsunaka T, Hamada M, Matsumoto Y, Higaki J. First-pass myocardial perfusion defect and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with MRI. Magn Reson Med Sci 2003;2:61–69.

    Article  PubMed  Google Scholar 

  9. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802–1809.

    PubMed  CAS  Google Scholar 

  10. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54–59.

    Article  PubMed  CAS  Google Scholar 

  11. Choudhury L, Mahrholdt H, Wagner A, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:2156–2164.

    Article  PubMed  Google Scholar 

  12. Bogaert J, Goldstein M, Tannouri F, Golzarian J, Dymarkowski S. Original report. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging. AJR Am J Roentgenol 2003;180:981–985.

    PubMed  Google Scholar 

  13. Neubauer S, Krahe T, Schindler R, et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992;86:1810–1818.

    PubMed  CAS  Google Scholar 

  14. Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997;96:2190–2196.

    PubMed  CAS  Google Scholar 

  15. Jung WI, Sieverding L, Breuer J, et al. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998;97:2536–2542.

    PubMed  CAS  Google Scholar 

  16. Pauschinger M, Chandrasekharan K, Schultheiss HP. Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system. Heart Fail Rev 2004;9:21–31.

    Article  PubMed  CAS  Google Scholar 

  17. Maisch B, Richter A, Sandmoller A, Portig I, Pankuweit S. Inflammatory dilated cardiomyopathy (DCMI). Herz 2005;30:535–544.

    Article  PubMed  Google Scholar 

  18. Kandolf R, Klingel K, Zell R, et al. Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology 1993;35(1–4):140–151.

    PubMed  CAS  Google Scholar 

  19. Brown CA, O’Connell JB. Myocarditis and idiopathic dilated cardiomyopathy. Am J Med 1995;99:309–314.

    Article  PubMed  CAS  Google Scholar 

  20. Schultheiss HP, Kuhl U. Overview on chronic viral cardiomyopathy/chronic myocarditis. Ernst Schering Res Found Workshop 2006(55):3–18.

    Article  PubMed  Google Scholar 

  21. Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005;45:1815–1822.

    Article  PubMed  Google Scholar 

  22. Strohm O, Schulz-Menger J, Pilz B, Osterziel KJ, Dietz R, Friedrich MG. Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J Magn Reson Imaging 2001;13:367–371.

    Article  PubMed  CAS  Google Scholar 

  23. Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2000;2:271–278.

    Article  PubMed  CAS  Google Scholar 

  24. Nazarian S, Bluemke DA, Lardo AC, et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005;112:2821–2825.

    Article  PubMed  Google Scholar 

  25. Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991;68:1388–1392.

    Article  PubMed  CAS  Google Scholar 

  26. Wesslen L, Ehrenborg C, Holmberg M, et al. Subacute bartonella infection in Swedish orienteers succumbing to sudden unexpected cardiac death or having malignant arrhythmias. Scand J Infect Dis 2001;33:429–438.

    Article  PubMed  CAS  Google Scholar 

  27. Saphir O. Acute myocarditis in sudden and unexpected death. Postgrad Med 1955;18:A-38–A-44.

    Google Scholar 

  28. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987;18:619–624.

    Article  PubMed  CAS  Google Scholar 

  29. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006;113:593–595.

    Article  PubMed  Google Scholar 

  30. Friedrich MG, Strohm O, Schulz-Menger JE, Marciniak H, Dietz R. Noninvasive diagnosis of acute myocarditis by contrast-enhanced magnetic resonance imaging. Proceedings of the ISMRM 6th Annual Meeting, Sydney 1998:912.

    Google Scholar 

  31. Laissy JP, Messin B, Varenne O, et al. MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. Chest 2002;122:1638–1648.

    Article  PubMed  Google Scholar 

  32. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250–1258.

    Article  PubMed  Google Scholar 

  33. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T 2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004;109:2411–2416.

    Article  PubMed  Google Scholar 

  34. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388–1398.

    Article  PubMed  CAS  Google Scholar 

  35. Ishikawa K. “Takotsubo” cardiomyopathy. A syndrome characterized by transient left ventricular apical ballooning that mimics the shape of a bottle used for trapping octopus in Japan. Intern Med 2004;43:275–276

    Article  PubMed  Google Scholar 

  36. Ako J, Kozaki K, Yoshizumi M, Ouchi Y. Transient left ventricular apical ballooning without coronary artery stenosis: a form of stunning-like phenomenon? J Am Coll Cardiol 2002;39:741–742.

    Article  PubMed  Google Scholar 

  37. Abe Y, Kondo M. Apical ballooning of the left ventricle: a distinct entity? Heart 2003;89:974–976.

    Article  PubMed  CAS  Google Scholar 

  38. Sharkey SW, Lesser JR, Zenovich AG, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 2005;111:472–479.

    Article  PubMed  Google Scholar 

  39. Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning to sudden emotional stress. N Engl J Med 2005;352:539–548.

    Article  PubMed  CAS  Google Scholar 

  40. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687–1713.

    Article  PubMed  Google Scholar 

  41. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112:855–861.

    Article  PubMed  Google Scholar 

  42. Schulz-Menger J, Strohm O, Waigand J, Uhlich F, Dietz R, Friedrich MG. The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. Circulation 2000;101:1764–1766.

    PubMed  CAS  Google Scholar 

  43. Paz R, Jortner R, Tunick PA, et al. The effect of the ingestion of ethanol on obstruction of the left ventricular outflow tract in hypertrophic cardiomyopathy. N Engl J Med 1996;335:938–941.

    Article  PubMed  CAS  Google Scholar 

  44. Kizilbash AM, Heinle SK, Grayburn PA. Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy. Circulation 1998;97:461–466.

    PubMed  CAS  Google Scholar 

  45. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561–1567.

    Article  PubMed  Google Scholar 

  46. Wilson JM, Villareal RP, Hariharan R, Massumi A, Muthupillai R, Flamm SD. Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. Tex Heart Inst J 2002;29:176–180.

    PubMed  Google Scholar 

  47. Moon JC, Reed E, Sheppard MN, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43:2260–2264.

    Article  PubMed  Google Scholar 

  48. Gietzen FH, Leuner CJ, Obergassel L, Strunk-Mueller C, Kuhn H. Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions. Circulation 2002;106:454–459.

    Article  PubMed  Google Scholar 

  49. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211–214.

    Article  PubMed  CAS  Google Scholar 

  50. Schulz-Menger J, Gross M, Messroghli D, Uhlich F, Dietz R, Friedrich MG. Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol 2003;42:513–518.

    Article  PubMed  Google Scholar 

  51. van Dockum WG, Beek AM, ten Cate FJ, et al. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 2005;111:2503–2508.

    Article  PubMed  Google Scholar 

  52. van Dockum WG, ten Cate FJ, ten Berg JM, et al. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 2004;43:27–34.

    Article  PubMed  Google Scholar 

  53. Tandri H, Friedrich MG, Calkins H, Bluemke DA. MRI of arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Magn Reson 2004;6:557–563.

    Article  PubMed  Google Scholar 

  54. Keller DI, Osswald S, Bremerich J, et al. Arrhythmogenic right ventricular cardiomyopathy: diagnostic and prognostic value of the cardiac MRI in relation to arrhythmia-free survival. Int J Cardiovasc Imaging 2003;19:537–543;discussion 545–537.

    Article  PubMed  Google Scholar 

  55. Bluemke DA, Krupinski EA, Ovitt T, et al. MR imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability. Cardiology 2003;99:153–162.

    Article  PubMed  Google Scholar 

  56. Menghetti L, Basso C, Nava A, Angelini A, Thiene G. Spin-echo nuclear magnetic resonance for tissue characterisation in arrhythmogenic right ventricular cardiomyopathy. Heart 1996;76:467–470.

    Article  PubMed  CAS  Google Scholar 

  57. Tansey DK, Aly Z, Sheppard MN. Fat in the right ventricle of the normal heart. Histopathology 2005;46:98–104.

    Article  PubMed  CAS  Google Scholar 

  58. Basso C, Thiene G. Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat? Cardiovasc Pathol 2005;14:37–41.

    Article  PubMed  Google Scholar 

  59. Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005;45:98–103.

    Article  PubMed  Google Scholar 

  60. Desai MY, Gupta S, Bomma C, et al. The apparent inversion time for optimal delayed enhancement magnetic resonance imaging differs between the right and left ventricles. J Cardiovasc Magn Reson 2005;7:475–479.

    Article  PubMed  Google Scholar 

  61. Sen-Chowdhry S, Prasad SK, McKenna WJ. Arrhythmogenic right ventricular cardiomyopathy with fibrofatty atrophy, myocardial oedema, and aneurysmal dilation. Heart 2005;91:784.

    Article  PubMed  CAS  Google Scholar 

  62. Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med 1997;336:267–276.

    Article  PubMed  CAS  Google Scholar 

  63. Jarvinen VM, Kupari MM, Poutanen VP, Hekali PE. A simplified method for the determination of left atrial size and function using cine magnetic resonance imaging. Magn Reson Imaging 1996;14:215–226.

    Article  PubMed  CAS  Google Scholar 

  64. Barkhausen J, Hunold P, Eggebrecht H, et al. Detection and characterization of intracardiac thrombi on MR imaging. AJR Am J Roentgenol 2002;179:1539–1544.

    PubMed  Google Scholar 

  65. Ohyama H, Hosomi N, Takahashi T, et al. Comparison of magnetic resonance imaging and transesophageal echocardiography in detection of thrombus in the left atrial appendage. Stroke 2003;34:2436–2439.

    Article  PubMed  Google Scholar 

  66. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001;88:1006–1010.

    Article  PubMed  CAS  Google Scholar 

  67. Sekiguchi M, Yazaki Y, Isobe M, Hiroe M. Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 1996;10:495–510.

    Article  PubMed  CAS  Google Scholar 

  68. Schulz-Menger J, Wassmuth R, Abdel-Aty H, et al. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart 2006;92:399–400.

    Article  PubMed  CAS  Google Scholar 

  69. Vignaux O, Dhote R, Duboc D, et al. Detection of myocardial involvement in patients with sarcoidosis applying T 2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr 2002;26:762–767.

    Article  PubMed  Google Scholar 

  70. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadoliniumenhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005;45:1683–1690.

    Article  PubMed  Google Scholar 

  71. Schulz-Menger J, Strohm O, Dietz R, Friedrich MG. Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging. Magma 2000;11:82–83.

    Article  PubMed  CAS  Google Scholar 

  72. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186–193.

    Article  PubMed  Google Scholar 

  73. Tscholakoff D, Aherne T, Yee ES, Derugin N, Higgins CB. Cardiac transplantations in dogs: evaluation with MR. Radiology 1985;157:697–702.

    PubMed  CAS  Google Scholar 

  74. Lund G, Morin RL, Olivari MT, Ring WS. Serial myocardial T 2 relaxation time measurements in normal subjects and heart transplant recipients. J Heart Transplant 1988;7:274–279.

    PubMed  CAS  Google Scholar 

  75. Doornbos J, Verwey H, Essed CE, Balk AH, de Roos A. MR imaging in assessment of cardiac transplant rejection in humans. J Comput Assist Tomogr 1990;14:77–81.

    Article  PubMed  CAS  Google Scholar 

  76. Sasaguri S, LaRaia PJ, Fabri BM, et al. Early detection of cardiac allograft rejection with proton nuclear magnetic resonance. Circulation 1985;72(3 pt 2):II231–II236.

    PubMed  CAS  Google Scholar 

  77. Marie PY, Angioi M, Carteaux JP, et al. Detection and prediction of acute heart transplant rejection with the myocardial T 2 determination provided by a black-blood magnetic resonance imaging sequence. J Am Coll Cardiol 2001;37:825–831.

    Article  PubMed  CAS  Google Scholar 

  78. Almenar L, Igual B, Martinez-Dolz L, et al. Utility of cardiac magnetic resonance imaging for the diagnosis of heart transplant rejection. Transplant Proc 2003;35:1962–1964.

    Article  PubMed  CAS  Google Scholar 

  79. Muehling OM, Panse P, Jerosch-Herold M, et al. Cardiac magnetic resonance perfusion imaging identifies transplant arteriopathy by a reduced endomyocardial resting perfusion. J Heart Lung Transplant 2005;24:1122–1123.

    Article  PubMed  Google Scholar 

  80. Westwood M, Anderson LJ, Firmin DN, et al. A single breath-hold multiecho T 2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003;18:33–39.

    Article  PubMed  Google Scholar 

  81. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in β-thalassaemia. Lancet 2002;360:516–520.

    Article  PubMed  CAS  Google Scholar 

  82. Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T 2* cardiovascular magnetic resonance. Br J Haematol 2004;127:348–355.

    Article  PubMed  CAS  Google Scholar 

  83. Pennell DJ, Berdoukas V, Karagiorga M, et al. Randomized controlled trial of deferiprone or deferoxamine in β-thalassemia major patients with asymptomatic myocardial siderosis. Blood. May 1 2006;107(9):3738–3744.

    Article  PubMed  CAS  Google Scholar 

  84. Celletti F, Fattori R, Napoli G, et al. Assessment of restrictive cardiomyopathy of amyloid or idiopathic etiology by magnetic resonance imaging. Am J Cardiol 1999;83:798–801, a710.

    Article  PubMed  CAS  Google Scholar 

  85. D’Silva SA, Kohli A, Dalvi BV, Kale PA. MRI in right ventricular endomyocardial fibrosis. Am Heart J 1992;123:1390–1392.

    Article  PubMed  Google Scholar 

  86. Wieneke H, Neumann T, Breuckmann F, et al. [Non-compaction cardiomyopathy]. Herz 2005;30:571–574.

    Article  PubMed  Google Scholar 

  87. Vatta M, Mohapatra B, Jimenez S, et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 2003;42:2014–2027.

    Article  PubMed  CAS  Google Scholar 

  88. Sedmera D, Pexieder T, Vuillemin M, Thompson RP, Anderson RH. Developmental patterning of the myocardium. Anat Rec 2000;258:319–337.

    Article  PubMed  CAS  Google Scholar 

  89. Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005;46:101–105.

    Article  PubMed  Google Scholar 

  90. Petersen SE, Timperley J, Neubauer S. Left ventricular thrombi in a patient with left ventricular non-compaction in visualisation of the rationale for anticoagulation. Heart 2005;91:e4.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stephenson CMR Centre at the Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada

    Hassan Abdel-Aty MD (Senior Fellow)

  2. University of Calgary, Calgary

    Matthias G. Friedrich MD (Associate Professor of Medicine and Director)

  3. Stephenson CMR Centre at the Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada

    Matthias G. Friedrich MD (Associate Professor of Medicine and Director)

Authors
  1. Hassan Abdel-Aty MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthias G. Friedrich MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Harvard Medical School, USA

    Raymond Y. Kwong MD, MPH (Instructor of Medicine and Director) (Instructor of Medicine and Director)

  2. Cardiac Magnetic Resonance Imaging, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts

    Raymond Y. Kwong MD, MPH (Instructor of Medicine and Director) (Instructor of Medicine and Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Abdel-Aty, H., Friedrich, M.G. (2008). Magnetic Resonance of Cardiomyopathies and Myocarditis. In: Kwong, R.Y. (eds) Cardiovascular Magnetic Resonance Imaging. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-306-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-306-6_19

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-673-3

  • Online ISBN: 978-1-59745-306-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation